- I-US Federal Food and Drug Administration ikhiphe ukukhunjulwa okuphuthumayo kwezinsiza zokuhlola ekhaya ezinephutha ze-COVID-19.
- Amakhithi okuhlola asekhaya akhunjulwe akhombisa imiphumela 'ephezulu-kunokwamukelekayo' ene-COVID-19 engamanga.
- Ukuhlolwa okuthola amaprotheni e-coronavirus, kugunyazwe ukusetshenziswa okuphuthumayo yi-FDA ngonyaka odlule.
'Ikilasi engikhumbulayo' lezigidi ezidumile ngokushesha Izinsiza zokuhlola i-COVID-19 ekhaya ikhishwe yi-US Federal Food and Drug Administration (FDA).
Ngokuvumelana ne FDA, 'uhlobo olubucayi kakhulu lokukhumbula' lukhishwe ngenxa yezinsiza zokuhlola ze-COVID-2,212,335 ezingu-19 ezikhiqizwe inkampani yase-Australia ye-biotech. U-Ellume, futhi isatshalaliswa e-US, ibonisa imiphumela yokuhlola 'ephakeme kunaleyo eyamukelekayo' ye-SARS-CoV-2 enamanga.
Umlawuli wenhlangano yaseMelika uxwayise ngokuthi ukusetshenziswa kwezinsizakusebenza ezinephutha "kungase kubangele imiphumela emibi yezempilo noma ukufa."
Ukuhlolwa kwe-antigen, okuthola amaprotheni e-coronavirus, kugunyazwe ukusetshenziswa okuphuthumayo yi-FDA ngonyaka odlule. Itholakala ngaphandle kwencwadi kadokotela kubo bobabili abantu abadala nezingane ezineminyaka emibili nangaphezulu, futhi isebenzisa amasampula e-swab athathwe ekhaleni ukuthola ukuthi umuntu une-COVID-19 yini.
Ezinye "izinkatho ezithile," ezenziwe phakathi kukaFebhuwari no-Agasti kulo nyaka, manje sezikhunjulwa e-US, inkampani ithi isebenze neziphathimandla ukukhipha ngokuzithandela izivivinyo ezithintekile emakethe.
Le nkampani ixolise “nganoma ikuphi ukucindezeleka noma ubunzima [amakhasimende] okungenzeka abuthole ngenxa yomphumela omuhle ongamanga.”
Imiphumela yamanga 'ephakeme kunale eyamukelekayo', ebonisa ukuthi umuntu une-coronavirus kuyilapho empeleni engenayo, ibikwe ku-FDA okungenani ezimweni ezingama-35. Ayikho imiphumela engemihle engemihle etholiwe.
Nokho, ukuxilonga okunganembile kungaba nemiphumela esongela ukuphila. Umuntu angase athole ukwelashwa okungalungile noma okungadingekile, okuhlanganisa nokwelashwa kwe-antiviral kanye ne-antibody, futhi ahlupheke okwengeziwe ngenxa yokuzihlukanisa namalungu omndeni nabangane.
Kungase futhi kuholele ekutheni abantu bangazinaki izinyathelo zokuphepha, okuhlanganisa nokugonyelwa i-COVID-19, kusho i-FDA.
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- Ezinye "izinkatho ezithile," ezenziwe phakathi kukaFebhuwari no-Agasti kulo nyaka, manje sezikhunjulwa e-US, inkampani ithi isebenze neziphathimandla ukukhipha ngokuzithandela izivivinyo ezithintekile emakethe.
- A ‘Class I recall' for millions of popular rapid COVID-19 home testing kits has been issued by the US Federal Food and Drug Administration (FDA).
- It is available without a prescription for both adults and children aged two and older, and uses swab samples taken from a nose to detect if one has COVID-19.
